Cencora, Inc. is involved in the sourcing and distribution of pharmaceutical products both in the U.S. and internationally. Its U.S. Healthcare Solutions segment generates revenue primarily from the distribution of generic and injectable pharmaceuticals (approximately 40%), over-the-counter healthcare products (20%), and specialty pharmaceuticals including plasma and vaccines (15%). The International Healthcare Solutions segment contributes about 25% of revenue through international pharmaceutical wholesale and related services. The company serves a diverse customer base including hospitals, pharmacies, and healthcare providers. Factors supporting its endurance include a long history in the industry and a broad service offering, while potential limitations may arise from regulatory changes and competition in the pharmaceutical distribution sector.
—
Cencora, Inc. is involved in the sourcing and distribution of pharmaceutical products both in the U.S. and internationally. Its U.S. Healthcare Solutions segment generates revenue primarily from the distribution of generic and injectable pharmaceuticals (approximately 40%), over-the-counter healthcare products (20%), and specialty pharmaceuticals including plasma and vaccines (15%). The International Healthcare Solutions segment contributes about 25% of revenue through international pharmaceutical wholesale and related services. The company serves a diverse customer base including hospitals, pharmacies, and healthcare providers. Factors supporting its endurance include a long history in the industry and a broad service offering, while potential limitations may arise from regulatory changes and competition in the pharmaceutical distribution sector.
—
Daily adjusted close
Cencora, Inc. is involved in the sourcing and distribution of pharmaceutical products both in the U.S. and internationally. Its U.S. Healthcare Solutions segment generates revenue primarily from the distribution of generic and injectable pharmaceuticals (approximately 40%), over-the-counter healthcare products (20%), and specialty pharmaceuticals including plasma and vaccines (15%). The International Healthcare Solutions segment contributes about 25% of revenue through international pharmaceutical wholesale and related services. The company serves a diverse customer base including hospitals, pharmacies, and healthcare providers. Factors supporting its endurance include a long history in the industry and a broad service offering, while potential limitations may arise from regulatory changes and competition in the pharmaceutical distribution sector.